Table 3.

Risk of CD in patients with low BMD compared with control groups evaluated by the same screening algorithms

AUTHOR, YEAR, COUNTRYCHARACTERISTICS OF PATIENTS WITH LOW BMDCHARACTERISTICS OF CONTROL GROUPCD PREVALENCE IN PATIENTS WITH LOW BMD, % (CASES/N)CD PREVALENCE IN CONTROL GROUP, % (CASES/N)P VALUE
Drummond et al,52 2003, Ireland366 women (82% postmenopausal) attending a bone densitometry unit
Mean age 56 y (range 28–96 y)
T-score ≤ −1.0
89 women (45% postmenopausal) attending the same bone densitometry unit
T-score > −1.0
2.2 (8/366)0 (0/89).364
González et al,53 2002, Argentina127 postmenopausal women
Mean age 68 y (range 50–82 y)
T-score < −2.5
747 women, mean age 29 y (range 16–79 y) attending an obligatory prenuptial examination in the same geographic area0.8 (1/127)0.8 (6/747)> .99
Sanders et al,572005, United Kingdom674 individuals (95% women) referred for DEXA scan from primary or secondary care
Mean age 53 y (range 21–69 y)
Total group: T-score ≤ −1.0
304 individuals of the same population
T-score > −1.0
1.5 (10/674)0.7 (2/304).360
Osteopenia: T-score −2.5 ≤ −1.01.2 (5/431)0.7 (2/304).7058
Osteoporosis: T-score ≤ −2.52.1 (5/243)0.7 (2/304).2505
Stenson et al,582005, United States266 individuals (90% female, most postmenopausal) attending a university bone clinic
Mean age 57 y
T-score ≤ −2.5
574 individuals (90% female, most postmenopausal) attending the same clinic
Mean age 63.2 y
T-score > −2.5
3.4 (9/266)0.2 (1/574)< .001
  • BMD—bone mineral density, CD—celiac disease, DEXA—dual-energy x-ray absorptiometry.